AI assistant
Sending…
Evogene Ltd. — Proxy Solicitation & Information Statement 2016
Feb 4, 2016
6785_rns_2016-02-04_36314971-f1ff-498b-918c-ce19913faecc.htm
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
_________ false
C002����� ��"�2PublicEVOGENE LTD10185Corporation no: 512838723Stock Exchange/Market: -12369380Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , ,Tel: 08-9311900 , Fax: 08-9466724E.mail address: [email protected] via MAGNA: 04/02/2016 Time of broadcast: 14:02 13:35:08
| Company site: | www.evogene.com |
Reference: 2016-02-023281
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Evogene Proxy Statement & Proxy Card for the Special General Meeting of shareholders |
| Evogene_2016_SGM_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| 2016-02-019228 |
| Previous names of reporting entity: |
| Date of revision of form structure: 31/01/2016 |
| - - - |
| Name of the Signatory: : Shalem Merav , Position of Signatory in the reporting corporation: Attorney/Legal Counsel , Name of Employer Company: . |
| Gad Feinstein St. Telephone: 08-9311900 , Facsimile: 08-9466724 , E-mail: [email protected] 1 |
More from Evogene Ltd.
Report Publication Announcement
2026
May 18
Regulatory Filings
2026
May 18
Foreign Filer Report
2026
May 18
Report Publication Announcement
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Apr 9
Director's Dealing
2026
Apr 9
Regulatory Filings
2026
Apr 2